CiteULike: Pseudomonas aeruginosa Exploits Lipid A and Muropeptides Modification as a Strategy to Lower Innate Immunity during Cystic Fibrosis Lung Infection.

CiteULike: Pseudomonas aeruginosa Exploits Lipid A and Muropeptides Modification as a Strategy to Lower Innate Immunity during Cystic Fibrosis Lung Infection.: "Cigana, C., Curcurù, L., Leone, M. R. R., Ieranò, T., Lorè, N. I. I., Bianconi, I., Silipo, A., Cozzolino, F., Lanzetta, R., Molinaro, A., Bernardini, M. L. L., and Bragonzi, A. (2009). Pseudomonas aeruginosa exploits lipid a and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PloS one, 4(12)."